These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 15765806)

  • 1. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.
    Cysique LA; Maruff P; Brew BJ
    J Neurovirol; 2004 Dec; 10(6):350-7. PubMed ID: 15765806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis.
    Cysique LA; Maruff P; Brew BJ
    J Int Neuropsychol Soc; 2006 May; 12(3):368-82. PubMed ID: 16903129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.
    McCutchan JA; Wu JW; Robertson K; Koletar SL; Ellis RJ; Cohn S; Taylor M; Woods S; Heaton R; Currier J; Williams PL
    AIDS; 2007 May; 21(9):1109-17. PubMed ID: 17502721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between AIDS retinal cotton wool spots and neuropsychological impairment in HIV-positive individuals in the pre-highly active antiretroviral therapy era.
    Freeman WR; McCutchan JA; Arevalo JF; Wolfson T; Marcotte TD; Heaton RK; Grant I;
    Ocul Immunol Inflamm; 2004 Mar; 12(1):25-33. PubMed ID: 15209461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.
    Cysique LA; Maruff P; Brew BJ
    Neurology; 2006 May; 66(9):1447-50. PubMed ID: 16682686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-associated cognitive impairment before and after the advent of combination therapy.
    Sacktor N; McDermott MP; Marder K; Schifitto G; Selnes OA; McArthur JC; Stern Y; Albert S; Palumbo D; Kieburtz K; De Marcaida JA; Cohen B; Epstein L
    J Neurovirol; 2002 Apr; 8(2):136-42. PubMed ID: 11935465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment and antiretroviral treatment in a Peruvian population of patients with human immunodeficiency virus.
    Guevara-Silva EA
    Neurologia; 2014 May; 29(4):224-9. PubMed ID: 23972623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda.
    Sacktor N; Nakasujja N; Skolasky RL; Robertson K; Musisi S; Ronald A; Katabira E; Clifford DB
    Neurology; 2009 Jan; 72(2):165-70. PubMed ID: 19139369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.
    Robinson-Papp J; Byrd D; Mindt MR; Oden NL; Simpson DM; Morgello S;
    Arch Neurol; 2008 Aug; 65(8):1096-101. PubMed ID: 18695060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004.
    Schneider MF; Gange SJ; Williams CM; Anastos K; Greenblatt RM; Kingsley L; Detels R; Muñoz A
    AIDS; 2005 Nov; 19(17):2009-18. PubMed ID: 16260908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
    Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
    Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy.
    Mönkemüller KE; Lazenby AJ; Lee DH; Loudon R; Wilcox CM
    Dig Dis Sci; 2005 Feb; 50(2):230-4. PubMed ID: 15745077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India.
    Gupta JD; Satishchandra P; Gopukumar K; Wilkie F; Waldrop-Valverde D; Ellis R; Ownby R; Subbakrishna DK; Desai A; Kamat A; Ravi V; Rao BS; Satish KS; Kumar M
    J Neurovirol; 2007 Jun; 13(3):195-202. PubMed ID: 17613709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.
    Cohen RA; Harezlak J; Schifitto G; Hana G; Clark U; Gongvatana A; Paul R; Taylor M; Thompson P; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B
    J Neurovirol; 2010 Feb; 16(1):25-32. PubMed ID: 20113183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.
    Arendt G; Nolting T; Frisch C; Husstedt IW; Gregor N; Koutsilieri E; Maschke M; Angerer A; Obermann M; Neuen-Jacob E; Adams O; Loeffert S; Riederer P; ter Meulen V; Sopper S;
    J Neurovirol; 2007 Jun; 13(3):225-32. PubMed ID: 17613712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
    Gallafent JH; Buskin SE; De Turk PB; Aboulafia DM
    J Clin Oncol; 2005 Feb; 23(6):1253-60. PubMed ID: 15718323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
    Gandhi T; Wei W; Amin K; Kazanjian P
    Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of progression to AIDS after HIV infection diagnosis in the pre- and post-HAART eras in a Brazilian AIDS-free cohort.
    Tancredi MV; Waldman EA
    Trans R Soc Trop Med Hyg; 2014 Jul; 108(7):408-14. PubMed ID: 24836061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.